TY  - GEN
AU  - Du,Jipei
AU  - Wang,Yufang
AU  - Chen,Degao
AU  - Ji,Guangyu
AU  - Ma,Qizhao
AU  - Liao,Shiping
AU  - Zheng,Yanjiang
AU  - Zhang,Ji
AU  - Hou,Yiping
TI  - BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-κB
SN  - 1872-7980
PY  - 2017///0808
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Apoptosis Regulatory Proteins
KW  - metabolism
KW  - Colonic Neoplasms
KW  - drug therapy
KW  - Drug Synergism
KW  - HCT116 Cells
KW  - Humans
KW  - Male
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Mutation
KW  - NF-kappa B
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Proto-Oncogene Proteins p21(ras)
KW  - genetics
KW  - Pyrimidines
KW  - Receptors, TNF-Related Apoptosis-Inducing Ligand
KW  - Signal Transduction
KW  - TNF-Related Apoptosis-Inducing Ligand
KW  - Time Factors
KW  - Transfection
KW  - Tumor Burden
KW  - Tumor Suppressor Protein p53
KW  - Up-Regulation
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.canlet.2016.10.002
ER  -